Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Ulf Wiinberg
AddedFeb 17, 2024
UpdatedMay 31, 2026
Ulf Wiinberg

Ulf Wiinberg

Board Member, Alfa Laval

CrunchbaseLinkedInThe Org

Ulf Wiinberg's Career

Alfa Laval
Alfa Laval

Lund, Skåne County, SE

Board Member· Board
Nestlé
Nestlé

Vevey, canton Vaud, CH

Board Member· Board
UCB
UCB

City of Brussels, Flemish Brabant, BE

Board Member· Board
X-Vax Technology
X-Vax Technology

Jupiter, FL, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Ulf Wiinberg's Career

Alfa Laval
Alfa Laval
Public21.1k1883Lund, Skåne County, SE
Board Member· Board

Leadership at Alfa Laval

Gustaf de LavalGustaf de LavalFounder
Ray MauritssonRay MauritssonBoard Member
Heléne MellquistHeléne MellquistBoard Member
Maria Moræus HanssenMaria Moræus HanssenBoard Member
Anna MüllerAnna MüllerBoard Member
Tom ErixonTom ErixonBoard Member

Similar to Alfa Laval

ElectroluxElectroluxStockholm, Stockholm County, SEAppliancesest. 1919ElectroluxStockholm, Stockholm County, SE · est. 1919

Swedish-based Electrolux AB manufactures and markets a wide range of home appliances globally.

Public · $1B51k
ABBABBZürich, Zürich, CHAutomation, Power, Roboticsest. 1988ABBZürich, Zürich, CH · est. 1988

ABB Ltd: A Swedish-Swiss firm offering power, automation technologies, and robotics solutions.

Public · $502.7M104.4k
SulzerSulzerWinterthur, Zürich, CHIndustrial Equipment, Pumpsest. 1834SulzerWinterthur, Zürich, CH · est. 1834

Sulzer AG, a Swiss industrial group, offers global pumping solutions, rotating equipment services, and application technology.

Public13k
Husqvarna GroupHusqvarna GroupHuskvarna, Jönköping County, SEOutdoor Power Productsest. 1689Husqvarna GroupHuskvarna, Jönköping County, SE · est. 1689

Swedish producer of outdoor power products and sewing machines, including mowers and chainsaws.

Public14.4k
Nestlé
Nestlé
Public275k1866Vevey, canton Vaud, CH
Board Member· Board

Leadership at Nestlé

Kimberly RossKimberly RossBoard Member
Henri de CastriesHenri de CastriesBoard Member
Ulf Mark SchneiderUlf Mark SchneiderBoard Member
Pablo Isla Álvarez de TejeraPablo Isla Álvarez de TejeraBoard Member
Daniel JhungDaniel JhungBoard Member
Rainer BlairRainer BlairBoard Member
UCB
UCB
Public$195.3M7.6k1928City of Brussels, Flemish Brabant, BE
Board Member· Board

Recent news

Castelion is raising a $350M Series B to scale hypersonic missile businessTechCrunch · 2025

Leadership at UCB

Jonathan PeacockJonathan PeacockBoard Member
Jean-Christophe TellierJean-Christophe TellierBoard Member
Jan BergerJan BergerBoard Member
Gerhard MayrGerhard MayrBoard Member
Stefan OschmannStefan OschmannBoard Member
Charles-Antoine JanssenCharles-Antoine JanssenBoard Member

Similar to UCB

Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
JanssenJanssenBeerse, Antwerp, BEPharmaceuticalsest. 1953JanssenBeerse, Antwerp, BE · est. 1953

Janssen, a Johnson & Johnson company in Italy, innovates to manage, interpret, and prevent diseases, ensuring affordable, effective healthcare worldwide.

Public255
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
SanofiSanofiParis, Paris, FRPharmaceuticalsest. 1973SanofiParis, Paris, FR · est. 1973

Sanofi, a global French pharmaceutical firm, manufactures prescription drugs and vaccines, specializing in various medical fields.

Public · $610M91.6k
X-Vax Technology
X-Vax Technology
Series A$56M392015Jupiter, FL, US
CEO· C-Suite · Management

Leadership at X-Vax Technology

Roger PomerantzRoger PomerantzBoard Member
Isaac BlechIsaac BlechBoard Member

Ulf Wiinberg's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Ulf Wiinberg

Romulo ColindresRomulo ColindresCEO · VitriVaxCasey DeLoachCasey DeLoachCEO · VaxCareMaurice ZaudererMaurice ZaudererBoard Member · VaccinexRobert R. RuffoloRobert R. RuffoloBoard Member · Elicio TherapeuticsDavid FriedmanDavid FriedmanCEO · XVionicsMichael SchraderMichael SchraderCo-Founder · Vaxess Technologies